Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

🚨Multiple Studies Confirm Ivermectin, Fenbendazole, & Mushrooms Exhibit Potent Anti-Cancer Activity via 20+ Mechanisms 💠Ivermectin: ✅ Proven safe—even with chemo ✅ Widespread anecdotal reports of remission ✅ 14 distinct anticancer mechanisms (systematic review) ✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more 💠Fenbendazole: ✅ Linked to remission of Stage...

NicHulscher's profile picture

Nicolas Hulscher, MPH

275,844 subscribers

199,492 görüntüleme • 11 ay önce •via X (Twitter)

Sağlık & İyilikBilim & Teknoloji
LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds
3:32

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 görüntüleme • 2 ay önce

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.
0:59

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

Joe Tippens

10,621 görüntüleme • 3 ay önce

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.
5:23

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

Joe Tippens

20,411 görüntüleme • 1 ay önce

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness
8:54

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness

skymeds store | Online Ivermectin Pharmacy

3,350,823 görüntüleme • 1 yıl önce

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,626 görüntüleme • 2 ay önce

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.
9:41

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 görüntüleme • 1 yıl önce

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole
5:52

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole

PharmacyinUSA

91,070 görüntüleme • 3 ay önce

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

25,225 görüntüleme • 2 ay önce

🚨 SKIN CANCER VANISHING? THE IVERMECTIN STORIES GOING VIRAL What started as curiosity turned into something many didn’t expect. Topical Ivermectin is getting attention for a reason: ✅ People report applying it directly to skin lesions and seeing visible changes over time ✅ Anecdotal cases describe shrinking of basal cell and squamous cell spots ✅ Some claim improvements in stubborn conditions like cystic acne after years of failed treatments ✅ Others mention changes in nodules, lipomas, and inflamed areas There are even reports of individuals noticing changes in localized swelling or lymph nodes with consistent topical use. Important context: These are real-world experiences, not large-scale clinical conclusions. Formal research on topical use for these conditions is still limited. But one thing is clear. People are experimenting, observing, and sharing outcomes that are hard to ignore. If you’re exploring Ivermectin, find trusted options through PharmacyinUSA.store #Ivermectin #Skincancer #Cancertreatment #Makismd #PharmacyinUSA
1:36

🚨 SKIN CANCER VANISHING? THE IVERMECTIN STORIES GOING VIRAL What started as curiosity turned into something many didn’t expect. Topical Ivermectin is getting attention for a reason: ✅ People report applying it directly to skin lesions and seeing visible changes over time ✅ Anecdotal cases describe shrinking of basal cell and squamous cell spots ✅ Some claim improvements in stubborn conditions like cystic acne after years of failed treatments ✅ Others mention changes in nodules, lipomas, and inflamed areas There are even reports of individuals noticing changes in localized swelling or lymph nodes with consistent topical use. Important context: These are real-world experiences, not large-scale clinical conclusions. Formal research on topical use for these conditions is still limited. But one thing is clear. People are experimenting, observing, and sharing outcomes that are hard to ignore. If you’re exploring Ivermectin, find trusted options through PharmacyinUSA.store #Ivermectin #Skincancer #Cancertreatment #Makismd #PharmacyinUSA

PharmacyinUSA.store

10,790 görüntüleme • 4 ay önce

🔥CANCER STEM CELLS: THE ROOT OF RESISTANCE Here are 10 foods proven in studies to help suppress or kill cancer stem cells: 🥇 Curcumin – From turmeric. Blocks self-renewal in breast and colon CSCs. 🥦 Sulforaphane – In broccoli sprouts. Eliminates tumor-initiating cells. 🍵 EGCG – Found in green tea. Shuts down Nanog and Oct4 stemness pathways. 🧅 Quercetin – In onions and capers. Reduces CSC markers like CD44. 🍇 Resveratrol – From grapes. Induces apoptosis in brain and colon CSCs. 🌿 Apigenin – In parsley and chamomile. Inhibits CSC migration and survival. 🫐 Pterostilbene – In blueberries. Disrupts mammary CSC formation. 🌱 Berberine – From herbs like goldenseal. Slows ovarian and liver CSC growth. 🥢 Genistein – In fermented soy. Targets Hedgehog + Notch CSC signaling. 🌸 Honokiol – From magnolia bark. Disarms glioblastoma stem cells. These foods target the real threat behind recurrence: cancer stem cells (CSCs). 📚 Studies confirm they inhibit stemness pathways like Wnt, Notch, Hedgehog, and VEGF, helping restore metabolic balance and starve resistance. ✅ Comment “PROTOCOL” for my full anti-cancer food + terrain guide ✅ Comment “EMAIL” for detox and stem cell targeting tips ✅ Comment “CONSULT” to work with me directly 📩 Check your messages for the links. If you don’t remove the root, the weed grows back. These foods help your body do what chemo can’t. ⚠️ DISCLAIMER: This content is for educational purposes only and is not intended to diagnose, treat, or cure any disease. Always consult your provider before starting any new protocols.
1:04

🔥CANCER STEM CELLS: THE ROOT OF RESISTANCE Here are 10 foods proven in studies to help suppress or kill cancer stem cells: 🥇 Curcumin – From turmeric. Blocks self-renewal in breast and colon CSCs. 🥦 Sulforaphane – In broccoli sprouts. Eliminates tumor-initiating cells. 🍵 EGCG – Found in green tea. Shuts down Nanog and Oct4 stemness pathways. 🧅 Quercetin – In onions and capers. Reduces CSC markers like CD44. 🍇 Resveratrol – From grapes. Induces apoptosis in brain and colon CSCs. 🌿 Apigenin – In parsley and chamomile. Inhibits CSC migration and survival. 🫐 Pterostilbene – In blueberries. Disrupts mammary CSC formation. 🌱 Berberine – From herbs like goldenseal. Slows ovarian and liver CSC growth. 🥢 Genistein – In fermented soy. Targets Hedgehog + Notch CSC signaling. 🌸 Honokiol – From magnolia bark. Disarms glioblastoma stem cells. These foods target the real threat behind recurrence: cancer stem cells (CSCs). 📚 Studies confirm they inhibit stemness pathways like Wnt, Notch, Hedgehog, and VEGF, helping restore metabolic balance and starve resistance. ✅ Comment “PROTOCOL” for my full anti-cancer food + terrain guide ✅ Comment “EMAIL” for detox and stem cell targeting tips ✅ Comment “CONSULT” to work with me directly 📩 Check your messages for the links. If you don’t remove the root, the weed grows back. These foods help your body do what chemo can’t. ⚠️ DISCLAIMER: This content is for educational purposes only and is not intended to diagnose, treat, or cure any disease. Always consult your provider before starting any new protocols.

Joe Tippens

13,813 görüntüleme • 2 ay önce

🚨 STAGE 4 BREAST CANCER. HOSPICE CARE. EIGHT MONTHS LATER, THE PET SCAN SHOCKED EVERYONE. A 33-year-old woman was facing a devastating diagnosis. Her breast cancer had returned. And this time it had spread. 📌 Liver 📌 Lungs 📌 Spine 📌 Pelvis 📌 Multiple vertebrae 📌 Bones A liver biopsy confirmed metastatic breast cancer. MRI scans showed cancer throughout her spine and skeletal system. PET scans revealed multiple hypermetabolic lung and bone lesions. The disease was widespread. By late 2021, she declined further conventional chemotherapy and was placed under hospice care. For many patients, that's where the story ends. But in November 2021, she began taking 222mg of Fenbendazole daily. At the start: • Cancer was confirmed in her liver • Cancer was confirmed in her bones • Multiple lung lesions were present • Tumor marker CA27.29 measured 316 Over the next several months, she continued taking 222mg of Fenbendazole daily. Then something remarkable happened. ✅ Liver enzymes returned to normal ✅ Tumor marker CA27.29 dropped from 316 to 36.6 ✅ Pain from spinal metastases improved And then came the PET scan. In April 2022, follow-up imaging reportedly showed no abnormal metabolic activity indicative of cancer. Think about that. The previous scans had shown active disease in the liver, lungs, spine, pelvis, and bones. Months later, the PET scan reportedly found no evidence of abnormal cancer activity. Cases like this are why Fenbendazole continues to attract attention around the world. Not because of opinions. Because people are looking at scans. Looking at lab results. Looking at outcomes. And deciding for themselves what questions deserve answers. 💊 Looking for Fenbendazole, Ivermectin, or Mebendazole? Explore RXMEDS.STORE. #Fenbendazole #BreastCancer #CancerResearch #RepurposedDrugs #Oncology #RxMeds
4:54

🚨 STAGE 4 BREAST CANCER. HOSPICE CARE. EIGHT MONTHS LATER, THE PET SCAN SHOCKED EVERYONE. A 33-year-old woman was facing a devastating diagnosis. Her breast cancer had returned. And this time it had spread. 📌 Liver 📌 Lungs 📌 Spine 📌 Pelvis 📌 Multiple vertebrae 📌 Bones A liver biopsy confirmed metastatic breast cancer. MRI scans showed cancer throughout her spine and skeletal system. PET scans revealed multiple hypermetabolic lung and bone lesions. The disease was widespread. By late 2021, she declined further conventional chemotherapy and was placed under hospice care. For many patients, that's where the story ends. But in November 2021, she began taking 222mg of Fenbendazole daily. At the start: • Cancer was confirmed in her liver • Cancer was confirmed in her bones • Multiple lung lesions were present • Tumor marker CA27.29 measured 316 Over the next several months, she continued taking 222mg of Fenbendazole daily. Then something remarkable happened. ✅ Liver enzymes returned to normal ✅ Tumor marker CA27.29 dropped from 316 to 36.6 ✅ Pain from spinal metastases improved And then came the PET scan. In April 2022, follow-up imaging reportedly showed no abnormal metabolic activity indicative of cancer. Think about that. The previous scans had shown active disease in the liver, lungs, spine, pelvis, and bones. Months later, the PET scan reportedly found no evidence of abnormal cancer activity. Cases like this are why Fenbendazole continues to attract attention around the world. Not because of opinions. Because people are looking at scans. Looking at lab results. Looking at outcomes. And deciding for themselves what questions deserve answers. 💊 Looking for Fenbendazole, Ivermectin, or Mebendazole? Explore RXMEDS.STORE. #Fenbendazole #BreastCancer #CancerResearch #RepurposedDrugs #Oncology #RxMeds

RXMEDS.STORE

16,476 görüntüleme • 2 ay önce

⚔️ BLOCKING GLUTAMINE NATURALLY When cancer cells can’t get glucose, they often switch to glutamine, a key amino acid involved in cell growth and repair. 🍄 Mistletoe—immune-regulating and disrupts glutamine-dependent cancer growth 🌿 Curcumin—shown to interfere with glutamine metabolism in aggressive tumors 🍵 Green tea (EGCG)—again, powerful here as well 🌿 Berberine—reduces expression of glutamine transporters 🧠 Honokiol (from magnolia bark)—neuroprotective and suppresses glutamine usage 🍄 Turkey tail mushroom—modulates immune response and may slow glutamine-driven cell replication 🥬 Fermented vegetables—rich in butyrate, which opposes glutamine-fueled inflammation 🥥 Coconut oil—encourages ketone metabolism over glutamine ✅ Suggested Stack: • AM: Honokiol + green tea • PM: Curcumin + mistletoe extract (consult with a practitioner) • Daily: Coconut oil for brain fuel + fermented foods for terrain healing 🧬 Avoid excess animal protein during active treatment—glutamine is abundant in meat. ✅ STUDIES: • Cell Metabolism (2013): Glutamine metabolism is essential for tumor growth in low-glucose environments. • Molecules (2020): Curcumin inhibits glutaminase, the enzyme that converts glutamine to fuel in cancer cells. • Frontiers in Oncology (2022): Mistletoe extract shown to downregulate glutamine pathways in colorectal cancer cells. • Oncotarget (2015): Honokiol targets mitochondrial glutamine metabolism in glioma models. 🔥Cancer adapts fast. But so can you. Block the second fuel… And give your body the upper hand it was designed to have. -Dr Pete Sulack
1:26

⚔️ BLOCKING GLUTAMINE NATURALLY When cancer cells can’t get glucose, they often switch to glutamine, a key amino acid involved in cell growth and repair. 🍄 Mistletoe—immune-regulating and disrupts glutamine-dependent cancer growth 🌿 Curcumin—shown to interfere with glutamine metabolism in aggressive tumors 🍵 Green tea (EGCG)—again, powerful here as well 🌿 Berberine—reduces expression of glutamine transporters 🧠 Honokiol (from magnolia bark)—neuroprotective and suppresses glutamine usage 🍄 Turkey tail mushroom—modulates immune response and may slow glutamine-driven cell replication 🥬 Fermented vegetables—rich in butyrate, which opposes glutamine-fueled inflammation 🥥 Coconut oil—encourages ketone metabolism over glutamine ✅ Suggested Stack: • AM: Honokiol + green tea • PM: Curcumin + mistletoe extract (consult with a practitioner) • Daily: Coconut oil for brain fuel + fermented foods for terrain healing 🧬 Avoid excess animal protein during active treatment—glutamine is abundant in meat. ✅ STUDIES: • Cell Metabolism (2013): Glutamine metabolism is essential for tumor growth in low-glucose environments. • Molecules (2020): Curcumin inhibits glutaminase, the enzyme that converts glutamine to fuel in cancer cells. • Frontiers in Oncology (2022): Mistletoe extract shown to downregulate glutamine pathways in colorectal cancer cells. • Oncotarget (2015): Honokiol targets mitochondrial glutamine metabolism in glioma models. 🔥Cancer adapts fast. But so can you. Block the second fuel… And give your body the upper hand it was designed to have. -Dr Pete Sulack

Cleanse Parasites .com 🧹🪱 Herbal Cleanse Co.

138,079 görüntüleme • 1 yıl önce

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds
5:47

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds

RXMEDS.STORE

353,990 görüntüleme • 1 ay önce

74% Of Doctors Would Refuse Chemotherapy For Their Own Cancer Treatment & Would Instead Use Alternative Real Cancer Cures For Themselves. Doctors Cite Chemotherapy As Unacceptably Cytotoxic & The 5 Year Survival Rate Is Only 2.1% Yet, Doctors Push Chemo Onto Their Own Patients. In the MacKillop et al study, only 17% of medical oncologists said that they would take chemotherapy for painful bone metastases & spine cancer. Even with modern chemotherapy, less than 30% of medical oncologists & oncology nurses would take chemotherapy. Cited in "The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies"... The overall contribution of curative & adjuvant cytotoxic chemotherapy to 5-year survival in adults is only 2.3% in Australia & 2.1% in the USA. Chemotherapy is incredibly toxic & must be handled in the clinical setting as a biohazard. Medical professionals who handle its contents in a hospital setting must wear protective gear for personal protection from the poisonous features of chemotherapy liquids. Chemotherapy came from one of the cruelest weapons ever invented as it was a weapon of war called Mustard Gas. Mustard Gas was banned in 1925 for being used as a weapon of war, citing it's deadly harm & inhumane use against war enemies. After that, researchers found it destroyed bone marrow & lymphatic tissue & decided to market it as a drug for profit. The 1st chemotherapy drug was Mechlorethamine Hydrochloride (HN2), which is a Nitrogen Mustard. Currently, 5 Nitrogen Mustards are used in Chemotherapy including Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan & Chlorambucil. Chemotherapy is not the answer for healing the body from cancer. Scientists Have Known Since the 1930s That Fasting Starves Cancer Cells… So Why Is It Ignored? 🤔 Dr. Otto Warburg (Nobel Prize winner) discovered that cancer cells thrive on glucose (sugar). He found that cancer cells have a damaged metabolism, meaning they rely almost entirely on fermenting sugar for energy—unlike healthy cells, which can switch to fat or ketones. ✅ Fasting drops blood sugar & insulin levels – Starving cancer of its preferred fuel. ✅ Increases ketones – Cancer cells cannot use ketones for energy & thus starve & die off. ✅ Triggers autophagy – The body removes damaged cells, including pre-cancerous ones. ✅ Boosts immune function – Fasting increases white blood cell regeneration, helping fight disease. 🚨 So why don’t doctors recommend fasting? Cancer treatment is a multi-billion dollar industry. Most oncologists don’t study nutrition or metabolic therapy. The system profits more from lifelong chemo & radiation patients than a free, natural intervention. Meanwhile, studies show fasting + a ketogenic diet slows tumor growth, shrinks tumors & makes complete remission possible. But instead of researching this further, mainstream medicine pushes drugs & expensive treatments. Dr William Makis & Dr Paul Marik, along with many leading physicians & oncologists have developed a groundbreaking protocol entitled: 'Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol' which involves a thorough step by step protocol of fasting & eliminating all glucose from the diet, while using ivermectin, fenbendazole & supportive nutrients & lifestyle changes for cancer treatment into remission. ⏩ ⏪ 👇Oncologists Would Not Choose Chemotherapy👇 👇5 Year Survival On Cancer Malignancies Chemo👇 👇Dr Thomas Seyfried: Cancer Metabolic Disease👇 Speaker: Dr Eric Berg
0:25

74% Of Doctors Would Refuse Chemotherapy For Their Own Cancer Treatment & Would Instead Use Alternative Real Cancer Cures For Themselves. Doctors Cite Chemotherapy As Unacceptably Cytotoxic & The 5 Year Survival Rate Is Only 2.1% Yet, Doctors Push Chemo Onto Their Own Patients. In the MacKillop et al study, only 17% of medical oncologists said that they would take chemotherapy for painful bone metastases & spine cancer. Even with modern chemotherapy, less than 30% of medical oncologists & oncology nurses would take chemotherapy. Cited in "The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies"... The overall contribution of curative & adjuvant cytotoxic chemotherapy to 5-year survival in adults is only 2.3% in Australia & 2.1% in the USA. Chemotherapy is incredibly toxic & must be handled in the clinical setting as a biohazard. Medical professionals who handle its contents in a hospital setting must wear protective gear for personal protection from the poisonous features of chemotherapy liquids. Chemotherapy came from one of the cruelest weapons ever invented as it was a weapon of war called Mustard Gas. Mustard Gas was banned in 1925 for being used as a weapon of war, citing it's deadly harm & inhumane use against war enemies. After that, researchers found it destroyed bone marrow & lymphatic tissue & decided to market it as a drug for profit. The 1st chemotherapy drug was Mechlorethamine Hydrochloride (HN2), which is a Nitrogen Mustard. Currently, 5 Nitrogen Mustards are used in Chemotherapy including Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan & Chlorambucil. Chemotherapy is not the answer for healing the body from cancer. Scientists Have Known Since the 1930s That Fasting Starves Cancer Cells… So Why Is It Ignored? 🤔 Dr. Otto Warburg (Nobel Prize winner) discovered that cancer cells thrive on glucose (sugar). He found that cancer cells have a damaged metabolism, meaning they rely almost entirely on fermenting sugar for energy—unlike healthy cells, which can switch to fat or ketones. ✅ Fasting drops blood sugar & insulin levels – Starving cancer of its preferred fuel. ✅ Increases ketones – Cancer cells cannot use ketones for energy & thus starve & die off. ✅ Triggers autophagy – The body removes damaged cells, including pre-cancerous ones. ✅ Boosts immune function – Fasting increases white blood cell regeneration, helping fight disease. 🚨 So why don’t doctors recommend fasting? Cancer treatment is a multi-billion dollar industry. Most oncologists don’t study nutrition or metabolic therapy. The system profits more from lifelong chemo & radiation patients than a free, natural intervention. Meanwhile, studies show fasting + a ketogenic diet slows tumor growth, shrinks tumors & makes complete remission possible. But instead of researching this further, mainstream medicine pushes drugs & expensive treatments. Dr William Makis & Dr Paul Marik, along with many leading physicians & oncologists have developed a groundbreaking protocol entitled: 'Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol' which involves a thorough step by step protocol of fasting & eliminating all glucose from the diet, while using ivermectin, fenbendazole & supportive nutrients & lifestyle changes for cancer treatment into remission. ⏩ ⏪ 👇Oncologists Would Not Choose Chemotherapy👇 👇5 Year Survival On Cancer Malignancies Chemo👇 👇Dr Thomas Seyfried: Cancer Metabolic Disease👇 Speaker: Dr Eric Berg

Valerie Anne Smith

286,806 görüntüleme • 11 ay önce

IVERMECTIN and LACTOFERRIN TESTIMONIAL - Oscar Nacu (Philippines, Aug.2022) IVERMECTIN and LACTOFERRIN Synergy Both compounds exhibit anticancer properties through overlapping pathways, such as inducing apoptosis (programmed cell death), modulating immune responses, and disrupting cancer cell metabolism and proliferation Lactoferrin can enhance Ivermectin’s effects by amplifying immune activation and oxidative stress, which may make cancer cells more vulnerable to IVM’s metabolic disruptions and apoptotic induction 1. Enhanced Apoptosis and Cell Death Pathways Individual Mechanisms: Lactoferrin induces apoptosis in cancer cells by damaging the cytoskeleton, activating caspases (e.g., caspase-3), upregulating pro-apoptotic proteins like BAX/BAK, and causing cell cycle arrest (e.g., G1/S or G2/M phases). It also reduces cell migration and invasion by reversing epithelial-mesenchymal transition (EMT), downregulating proteins like vimentin, SNAIL, and TWIST. Ivermectin promotes apoptosis via mitochondrial dysfunction, increasing reactive oxygen species (ROS), elevating the Bax/Bcl-2 ratio, and activating caspases 9/3. It also inhibits proliferation through cell cycle arrest and targets cancer stem cells. How They Work Together: Lactoferrin’s ability to induce oxidative stress and DNA damage complements Ivermectin’s ROS elevation and mitochondrial inhibition. This dual assault on cellular energy and redox balance could lower the threshold for apoptosis, making cancer cells more susceptible to Ivermectin’s effects 2. Immune Modulation and Tumor Microenvironment Remodeling Individual Mechanisms: Lactoferrin stimulates the adaptive immune response, reshapes the tumor microenvironment by downregulating pro-inflammatory cytokines (e.g., IL-6), and inhibits cancer progression through immunostimulatory effects. It also protects against iron disorders, depriving iron-dependent cancer cells while modulating immunity. Ivermectin has immunomodulatory properties, converting “cold” tumors (immune-deserted) to “hot” ones (immune-infiltrated) by inducing immunogenic cell death (ICD), releasing ATP and HMGB1, depleting immunosuppressive cells (e.g., MDSCs and Tregs), and enhancing CD8+ T-cell infiltration. How They Work Together: Lactoferrin’s cytokine downregulation and immune stimulation could amplify Ivermectin’s ICD and T-cell recruitment, creating a more hostile environment for cancer cells. For example, Ivermectin’s ability to boost Teff/Treg ratios pairs well with Lactoferrin’s anti-inflammatory effects, potentially enhancing overall antitumor immunity. 3. Disruption of Cancer Cell Metabolism and Proliferation Individual Mechanisms: Lactoferrin inhibits oncogenic pathways like PI3K/AKT/mTOR and Wnt, reducing proliferation and angiogenesis (e.g., downregulating VEGFR2). Ivermectin interferes with metabolic pathways, downregulating TCA cycle enzymes (e.g., IDH2, DLST), inhibiting glycolysis/oxidative phosphorylation, and limiting glutamine-derived intermediates for biosynthesis. How They Work Together: Lactoferrin’s iron sequestration starves cancer cells of essential metals for metabolic enzymes, synergizing with Ivermectin’s TCA cycle disruption to exacerbate energy shortages and biosynthetic limitations. This is particularly relevant in “glutamine-addicted” cancers like ovarian or prostate, where combined metabolic stress promotes apoptosis. (Podcast: Dr.Allan Landrito, Dr.Mahin Khatami, Dr.Shankara Chetty" === I have the world's largest Ivermectin Cancer Clientele, 7900 strong! Joseph A. Ladapo, MD, PhD
6:19

IVERMECTIN and LACTOFERRIN TESTIMONIAL - Oscar Nacu (Philippines, Aug.2022) IVERMECTIN and LACTOFERRIN Synergy Both compounds exhibit anticancer properties through overlapping pathways, such as inducing apoptosis (programmed cell death), modulating immune responses, and disrupting cancer cell metabolism and proliferation Lactoferrin can enhance Ivermectin’s effects by amplifying immune activation and oxidative stress, which may make cancer cells more vulnerable to IVM’s metabolic disruptions and apoptotic induction 1. Enhanced Apoptosis and Cell Death Pathways Individual Mechanisms: Lactoferrin induces apoptosis in cancer cells by damaging the cytoskeleton, activating caspases (e.g., caspase-3), upregulating pro-apoptotic proteins like BAX/BAK, and causing cell cycle arrest (e.g., G1/S or G2/M phases). It also reduces cell migration and invasion by reversing epithelial-mesenchymal transition (EMT), downregulating proteins like vimentin, SNAIL, and TWIST. Ivermectin promotes apoptosis via mitochondrial dysfunction, increasing reactive oxygen species (ROS), elevating the Bax/Bcl-2 ratio, and activating caspases 9/3. It also inhibits proliferation through cell cycle arrest and targets cancer stem cells. How They Work Together: Lactoferrin’s ability to induce oxidative stress and DNA damage complements Ivermectin’s ROS elevation and mitochondrial inhibition. This dual assault on cellular energy and redox balance could lower the threshold for apoptosis, making cancer cells more susceptible to Ivermectin’s effects 2. Immune Modulation and Tumor Microenvironment Remodeling Individual Mechanisms: Lactoferrin stimulates the adaptive immune response, reshapes the tumor microenvironment by downregulating pro-inflammatory cytokines (e.g., IL-6), and inhibits cancer progression through immunostimulatory effects. It also protects against iron disorders, depriving iron-dependent cancer cells while modulating immunity. Ivermectin has immunomodulatory properties, converting “cold” tumors (immune-deserted) to “hot” ones (immune-infiltrated) by inducing immunogenic cell death (ICD), releasing ATP and HMGB1, depleting immunosuppressive cells (e.g., MDSCs and Tregs), and enhancing CD8+ T-cell infiltration. How They Work Together: Lactoferrin’s cytokine downregulation and immune stimulation could amplify Ivermectin’s ICD and T-cell recruitment, creating a more hostile environment for cancer cells. For example, Ivermectin’s ability to boost Teff/Treg ratios pairs well with Lactoferrin’s anti-inflammatory effects, potentially enhancing overall antitumor immunity. 3. Disruption of Cancer Cell Metabolism and Proliferation Individual Mechanisms: Lactoferrin inhibits oncogenic pathways like PI3K/AKT/mTOR and Wnt, reducing proliferation and angiogenesis (e.g., downregulating VEGFR2). Ivermectin interferes with metabolic pathways, downregulating TCA cycle enzymes (e.g., IDH2, DLST), inhibiting glycolysis/oxidative phosphorylation, and limiting glutamine-derived intermediates for biosynthesis. How They Work Together: Lactoferrin’s iron sequestration starves cancer cells of essential metals for metabolic enzymes, synergizing with Ivermectin’s TCA cycle disruption to exacerbate energy shortages and biosynthetic limitations. This is particularly relevant in “glutamine-addicted” cancers like ovarian or prostate, where combined metabolic stress promotes apoptosis. (Podcast: Dr.Allan Landrito, Dr.Mahin Khatami, Dr.Shankara Chetty" === I have the world's largest Ivermectin Cancer Clientele, 7900 strong! Joseph A. Ladapo, MD, PhD

Dr. William Makis MD

48,226 görüntüleme • 7 ay önce

A Medical Paradigm Built on Warfare is Failing Cancer Patients. Here’s the Breakthrough They Are Blocking. Dr. Patrick Soon-Shiong reveals a hard truth: our cancer treatment roots are in mustard gas & nuclear weapons—a system of "short-term survival scarred by fear, power, and control." He believed groundbreaking science would be embraced. He was wrong. The discovery? Your body has the ultimate weapon: the Natural Killer (NK) cell. We can now activate it with a simple protein (IL-15), creating a universal key to attack ALL cancer types. The FDA’s fatal flaw? Bureaucratic inertia & regulatory capture. They approve drugs for anemia (Epogen) or low neutrophils (Neupogen) regardless of tumor type. It's logical: you don't ask why you need a blood transfusion. Yet, when patients have low NK & T cells (lymphopenia)—a $20 test reveals this—the FDA refuses to approve IL-15 as the universal solution. It's like denying a transfusion for catastrophic blood loss. The proof is there: - ✅ Bladder cancer patients alive & cancer-free for 10+ years. - ✅ Data for pancreatic, lung, & head/neck cancers. The response? "Refused to file." They demand a randomized trial for every single cancer type—a process requiring "three lifetimes" while patients die. This isn't just about cancer. The immune system is the key to longevity. The world's oldest person, 117, had hyper-active NK cells. We have a simple, subcutaneous shot that can save lives now. The system, prioritizing money & consensus over people, is standing in the way. It's time for a revolution in medicine. The power to heal is already within us.
5:53

A Medical Paradigm Built on Warfare is Failing Cancer Patients. Here’s the Breakthrough They Are Blocking. Dr. Patrick Soon-Shiong reveals a hard truth: our cancer treatment roots are in mustard gas & nuclear weapons—a system of "short-term survival scarred by fear, power, and control." He believed groundbreaking science would be embraced. He was wrong. The discovery? Your body has the ultimate weapon: the Natural Killer (NK) cell. We can now activate it with a simple protein (IL-15), creating a universal key to attack ALL cancer types. The FDA’s fatal flaw? Bureaucratic inertia & regulatory capture. They approve drugs for anemia (Epogen) or low neutrophils (Neupogen) regardless of tumor type. It's logical: you don't ask why you need a blood transfusion. Yet, when patients have low NK & T cells (lymphopenia)—a $20 test reveals this—the FDA refuses to approve IL-15 as the universal solution. It's like denying a transfusion for catastrophic blood loss. The proof is there: - ✅ Bladder cancer patients alive & cancer-free for 10+ years. - ✅ Data for pancreatic, lung, & head/neck cancers. The response? "Refused to file." They demand a randomized trial for every single cancer type—a process requiring "three lifetimes" while patients die. This isn't just about cancer. The immune system is the key to longevity. The world's oldest person, 117, had hyper-active NK cells. We have a simple, subcutaneous shot that can save lives now. The system, prioritizing money & consensus over people, is standing in the way. It's time for a revolution in medicine. The power to heal is already within us.

Camus

71,957 görüntüleme • 10 ay önce

🚨 Why did Rep. Scott Hilton (R–Peachtree Corners) side with Democrats by voting against medical freedom for Georgians? In the 3/19/26 Public & Community Health Committee: ⏱️ Hilton arrived 22 mins into a 30-min hearing ⏱️ 26:23 – Dem motion to REMOVE OTC ivermectin ⏱️ 28:11 – Hilton = ONLY Republican voting with Democrats ⏱️ 30:00 – Did NOT vote with Republicans to support SB 440 with OTC ivermectin Meanwhile, Republicans who stood for access: 👏 Karen Mathiak, James Burchett, Mike Cheokas, Lee Hawkins, Angie O’Steen, Gary Richardson, Devan Seabaugh, Darlene Taylor. 💪 Rep. Dunahoo for strong testimony 👏Thank you Sharon Cooper for hearing SB440 w amendment. 📌 Ivermectin: FDA-approved antiparasitic that increases chloride permeability in parasites → parasite paralysis/death ▪️ Also shows anti-inflammatory effects (cytokine inhibition) ▪️ Under study for potential anticancer mechanisms* 🏆Nobel Prize in Medicine 2015 📌 Iivermectin is available (no doctor Rx required) • Tennessee (since 2022 — first) • Arkansas (2025) • Idaho (2025) • Louisiana (June 2025) • Texas (Dec 4, 2025) 🌍 Widely accessible globally: • Mexico — OTC in pharmacies • Latin America (Brazil, Peru, others) • India, Thailand + much of Asia & Africa 🐄 Veterinary ivermectin = OTC in many places worldwide Why break ranks by voting against medical freedom for Georgians Rep. Scott Hilton 🇺🇸 ?🤔 GA House Republicans Georgia House of Representatives JonBurnsGA Jan Jones Chuck Efstration Representative James Burchett Soo Hong GA State Representative Ginny Ehrhart Rep. Lee Hawkins Rep. Karen Mathiak Dale Washburn GA Senate Republicans Georgia State Senate Lt. Governor Burt Jones Jason R. Anavitarte Randy Robertson Senator Clint Dixon Kay kirkpatrick Bo Hatchett Russ Goodman Ed Setzler Chuck Hufstetler Matt Brass Marty Harbin Ben Watson Rick Williams Governor Brian P. Kemp Senator Greg Dolezal Blake Tillery Steve Gooch David Clark Bill Cowsert Brian Strickland For Georgia Kelvin King * Ivermectin Shows Striking Anticancer Potential and Remarkable Safety: “Preclinical studies in cell lines and animal models have demonstrated that ivermectin exerts anticancer effects through multiple, tumor-suppressive mechanisms, including: •Inhibition of YAP1 (Yes-associated protein 1) nuclear translocation •Suppression of the Wnt/TCF (T-cell factor) signaling pathway •Degradation of p21-activated kinase 1 (PAK1) •Inhibition of the AKT/mTOR signaling cascade •Induction of mitochondrial dysfunctionand oxidative stress •Activation of caspase-dependent apoptosis These mechanisms have been observed across several cancer types, notably: •Glioblastoma •Ovarian cancer •Chronic myeloid leukemia (CML) •Cervical cancer Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy.” Dr. Michelle Au Representative Park Cannon Stacey Evans Georgia House Democrats Georgia Senate Democrats Senator Sonya Halpern
30:24

🚨 Why did Rep. Scott Hilton (R–Peachtree Corners) side with Democrats by voting against medical freedom for Georgians? In the 3/19/26 Public & Community Health Committee: ⏱️ Hilton arrived 22 mins into a 30-min hearing ⏱️ 26:23 – Dem motion to REMOVE OTC ivermectin ⏱️ 28:11 – Hilton = ONLY Republican voting with Democrats ⏱️ 30:00 – Did NOT vote with Republicans to support SB 440 with OTC ivermectin Meanwhile, Republicans who stood for access: 👏 Karen Mathiak, James Burchett, Mike Cheokas, Lee Hawkins, Angie O’Steen, Gary Richardson, Devan Seabaugh, Darlene Taylor. 💪 Rep. Dunahoo for strong testimony 👏Thank you Sharon Cooper for hearing SB440 w amendment. 📌 Ivermectin: FDA-approved antiparasitic that increases chloride permeability in parasites → parasite paralysis/death ▪️ Also shows anti-inflammatory effects (cytokine inhibition) ▪️ Under study for potential anticancer mechanisms* 🏆Nobel Prize in Medicine 2015 📌 Iivermectin is available (no doctor Rx required) • Tennessee (since 2022 — first) • Arkansas (2025) • Idaho (2025) • Louisiana (June 2025) • Texas (Dec 4, 2025) 🌍 Widely accessible globally: • Mexico — OTC in pharmacies • Latin America (Brazil, Peru, others) • India, Thailand + much of Asia & Africa 🐄 Veterinary ivermectin = OTC in many places worldwide Why break ranks by voting against medical freedom for Georgians Rep. Scott Hilton 🇺🇸 ?🤔 GA House Republicans Georgia House of Representatives JonBurnsGA Jan Jones Chuck Efstration Representative James Burchett Soo Hong GA State Representative Ginny Ehrhart Rep. Lee Hawkins Rep. Karen Mathiak Dale Washburn GA Senate Republicans Georgia State Senate Lt. Governor Burt Jones Jason R. Anavitarte Randy Robertson Senator Clint Dixon Kay kirkpatrick Bo Hatchett Russ Goodman Ed Setzler Chuck Hufstetler Matt Brass Marty Harbin Ben Watson Rick Williams Governor Brian P. Kemp Senator Greg Dolezal Blake Tillery Steve Gooch David Clark Bill Cowsert Brian Strickland For Georgia Kelvin King * Ivermectin Shows Striking Anticancer Potential and Remarkable Safety: “Preclinical studies in cell lines and animal models have demonstrated that ivermectin exerts anticancer effects through multiple, tumor-suppressive mechanisms, including: •Inhibition of YAP1 (Yes-associated protein 1) nuclear translocation •Suppression of the Wnt/TCF (T-cell factor) signaling pathway •Degradation of p21-activated kinase 1 (PAK1) •Inhibition of the AKT/mTOR signaling cascade •Induction of mitochondrial dysfunctionand oxidative stress •Activation of caspase-dependent apoptosis These mechanisms have been observed across several cancer types, notably: •Glioblastoma •Ovarian cancer •Chronic myeloid leukemia (CML) •Cervical cancer Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy.” Dr. Michelle Au Representative Park Cannon Stacey Evans Georgia House Democrats Georgia Senate Democrats Senator Sonya Halpern

WhatmattersinGeorgia

38,327 görüntüleme • 5 ay önce

Ivermectin and Mebendazole in Cancer Patients The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Overall, it is estimated that annual costs of standard chemotherapies average $111,000 per year. Background: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole have demonstrated multi-target anti-cancer activity. This paper evaluates real-world patient-reported outcomes, safety, and adherence in a cohort of cancer patients utilizing this combination protocol. Methods: Prospective observational cohort of 197 cancer patients, who were prescribed ivermectin and mebendazole off-label through telemedicine (platform by licensed U.S. healthcare providers) Participants received compounded oral capsules containing 25 mg ivermectin and 250 mg mebendazole. Data were collected via voluntary, standardized digital surveys at baseline and at approximately 6-month follow-up. Of the initial cohort (N = 197), baseline characteristics, including cancer type and disease status, were assessed. A total of 122 participants completed the follow-up survey (61.9% response rate) Results: Mean age of 67 years, (52.3% male, 47.7% female). Cancer types included Prostate 27.9% Breast 18.3% Lung 8.6% Colon 5.1% Urologic 4.6% Pancreatic 3.0% Liver 2.5% Gynaecologic 2.5% Hematologic 2.5% Median duration since initial diagnosis, 1.2 years 37.1% experiencing active disease progression. 6-month follow-up Medication adherence, 86.9% Full initial 90-capsule ivermectin-mebendazole prescription. The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Notably, 48.4% of cohort, strongest positive outcomes: Regression, 15.6% No current evidence of disease (NED), 32.8% Disease stability, 36.1% Disease progression, 15.6% No significant dose-response association was observed for cancer outcomes (p = 0.91), without a clear dose-response gradient for efficacy. Side effects Mild side effects (primarily gastrointestinal), 25.4% (93.6% of those affected continued treatment through minor dose adjustments) Concurrent conventional therapies Chemotherapy, 27.9% Radiation therapy, 21.3% Surgery, 19.7% Adjunctive interventions such as supplement use, 49.2% Dietary modification, 37.7% Conclusions: In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumours regression or no current evidence of disease across a heterogeneous population of cancer patients. These findings provide a compelling clinical signal that these well-tolerated, repurposed agents may offer therapeutic benefit. However, observational design, reliance on self-reported outcomes, and potential for selection bias and uncontrolled confounding, these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials Validate these observations and further define optimal dosing strategies. Mechanism (pharmacodynamics) Ivermectin and mebendazole are antiparasitic agents, demonstrated highly promising anti-cancer activity. Ivermectin Shown to exert over 14 distinct anti-cancer mechanisms across more than 12 cancer types, inhibiting cancer cell proliferation, metastasis, angiogenesis, mitochondrial function. Has demonstrated excellent safety in cancer patients (including those actively undergoing chemotherapy) Ivermectin and mebendazole selectively target cancer stem cells Mebendazole Microtubule disruption, leading to effective cell cycle arrest Potent induction of apoptosis Significant inhibition of tumour growth Inhibition of angiogenesis Disruption of glucose uptake When used together Target non-overlapping pathways, resulting in synergistic tumour regression, cancer stem cell depletion, and reversal of multidrug resistance in multiple in vitro and in vivo models Biodistribution, ivermectin and mebendazole document excellent tissue penetration
24:40

Ivermectin and Mebendazole in Cancer Patients The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Overall, it is estimated that annual costs of standard chemotherapies average $111,000 per year. Background: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole have demonstrated multi-target anti-cancer activity. This paper evaluates real-world patient-reported outcomes, safety, and adherence in a cohort of cancer patients utilizing this combination protocol. Methods: Prospective observational cohort of 197 cancer patients, who were prescribed ivermectin and mebendazole off-label through telemedicine (platform by licensed U.S. healthcare providers) Participants received compounded oral capsules containing 25 mg ivermectin and 250 mg mebendazole. Data were collected via voluntary, standardized digital surveys at baseline and at approximately 6-month follow-up. Of the initial cohort (N = 197), baseline characteristics, including cancer type and disease status, were assessed. A total of 122 participants completed the follow-up survey (61.9% response rate) Results: Mean age of 67 years, (52.3% male, 47.7% female). Cancer types included Prostate 27.9% Breast 18.3% Lung 8.6% Colon 5.1% Urologic 4.6% Pancreatic 3.0% Liver 2.5% Gynaecologic 2.5% Hematologic 2.5% Median duration since initial diagnosis, 1.2 years 37.1% experiencing active disease progression. 6-month follow-up Medication adherence, 86.9% Full initial 90-capsule ivermectin-mebendazole prescription. The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Notably, 48.4% of cohort, strongest positive outcomes: Regression, 15.6% No current evidence of disease (NED), 32.8% Disease stability, 36.1% Disease progression, 15.6% No significant dose-response association was observed for cancer outcomes (p = 0.91), without a clear dose-response gradient for efficacy. Side effects Mild side effects (primarily gastrointestinal), 25.4% (93.6% of those affected continued treatment through minor dose adjustments) Concurrent conventional therapies Chemotherapy, 27.9% Radiation therapy, 21.3% Surgery, 19.7% Adjunctive interventions such as supplement use, 49.2% Dietary modification, 37.7% Conclusions: In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumours regression or no current evidence of disease across a heterogeneous population of cancer patients. These findings provide a compelling clinical signal that these well-tolerated, repurposed agents may offer therapeutic benefit. However, observational design, reliance on self-reported outcomes, and potential for selection bias and uncontrolled confounding, these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials Validate these observations and further define optimal dosing strategies. Mechanism (pharmacodynamics) Ivermectin and mebendazole are antiparasitic agents, demonstrated highly promising anti-cancer activity. Ivermectin Shown to exert over 14 distinct anti-cancer mechanisms across more than 12 cancer types, inhibiting cancer cell proliferation, metastasis, angiogenesis, mitochondrial function. Has demonstrated excellent safety in cancer patients (including those actively undergoing chemotherapy) Ivermectin and mebendazole selectively target cancer stem cells Mebendazole Microtubule disruption, leading to effective cell cycle arrest Potent induction of apoptosis Significant inhibition of tumour growth Inhibition of angiogenesis Disruption of glucose uptake When used together Target non-overlapping pathways, resulting in synergistic tumour regression, cancer stem cell depletion, and reversal of multidrug resistance in multiple in vitro and in vivo models Biodistribution, ivermectin and mebendazole document excellent tissue penetration

Dr. Zakaria MD

10,766 görüntüleme • 2 ay önce

Post 🇫🇷 & 🇺🇸 🇫🇷🚨⚠️ Attention hautement TABOU‼️ Et si on soignait le #CANCER mais qu’on nous le cachait sciemment ? NON, mais NON, ils n’oseraient pas, n’est-ce pas ? Et si on vous disait que certains vermifuges pour chiens pourraient être un traitement efficace contre le cancer ? Pourquoi ces résultats nous sont-ils cachés ? Quels sont les véritables intérêts de #BigPharma à nous cacher tant de vérités ? L’heure des révélations a sonné. Plus rien ne pourra les arrêter. Les témoignages se MULTIPLIENT. Écoutez ATTENTIVEMENT ces 4 vidéos que j’ai traduites, allant de #MelGibson à des médecins… ♦️ Vidéo 1 Mel Gibson Fan affirme que trois de ses amis atteints de cancer de stade 4 sont désormais en rémission, après avoir utilisé… ♦️ Vidéo 2 Dr. Kathleen Ruddy confirme que des patients en phase terminale de cancer ont guéri de manière spectaculaire après avoir pris de l’Ivermectine, avec des scans montrant la disparition des tumeurs… ♦️ Vidéo 3 Le Fenbendazole est de plus en plus reconnu comme un traitement anticancéreux potentiel. Il agit en déstabilisant les microtubules, ce qui perturbe la division des cellules cancéreuses et ralentit ou arrête la croissance des tumeurs. ♦️Vidéo 4 Joe Tippens, atteint d’un cancer du poumon en phase terminale avec moins de 1 % de chances de survie, attribue SA guérison à l’utilisation du Fenbendazole, un médicament pour animaux, après avoir reçu le conseil d’un vétérinaire. Trois mois plus tard, son cancer avait disparu, laissant les médecins PERPLEXES. 🇺🇸🚨⚠️ Highly TABOO alert‼️ What if cancer could be cured, but we were deliberately kept in the dark? NO, but NO, they wouldn’t dare, would they? What if we told you that some dog dewormers could be an effective treatment for cancer? Why are these results being hidden from us? What are the real interests of Big Pharma in concealing such truths? The time for truth has arrived. Nothing will stop them now. The testimonies are MULTIPLYING. Listen CLOSELY to these 4 videos I translated, from #MelGibson to doctors… ♦️ Video 1: Mel Gibson claims that three of his friends diagnosed with stage 4 cancer are now in remission after using… ♦️ Video 2: Dr. Kathleen Ruddy confirms that terminal cancer patients have made dramatic recoveries after taking Ivermectin, with scans showing the disappearance of tumors… ♦️ Video 3: Fenbendazole is increasingly recognized as a potential anti-cancer treatment. It works by destabilizing microtubules, disrupting cancer cell division, and slowing or stopping tumor growth. ♦️ Video 4: Joe Tippens, diagnosed with terminal lung cancer and given less than a 1% chance of survival, credits his recovery to the use of Fenbendazole, a pet medication, after receiving advice from a veterinarian. Three months later, his cancer had disappeared, leaving doctors PERPLEXED. #NCSWIC ♦️🇫🇷 Mes précédents postes sur Mel Gibson / 🇺🇸 My previous posts about Mel Gibson ➡️ & ➡️ ♦️ Source vidéos The Vigilant Fox 🦊 🇺🇸🦅🇫🇷 Sylvia Miami 🇫🇷🦅🇺🇸 🔴 Tous mes liens en un seul clic, suivez-moi / All my links in one click, follow me ✅ Donald J. Trump General Mike Flynn Elon Musk Robert F. Kennedy Jr #sylviamiami #Actu #Tendance #Infos #Monde #trump #maga #MAHA #RFKjr #RobertFKennedyJr #elonmusk #Cancer #Ivermectine #Fenbendazole #TraitementsAlternatifs #NaturalHealing #Ivermectin #Health #Remission #AlternativeTreatments
1:27

Post 🇫🇷 & 🇺🇸 🇫🇷🚨⚠️ Attention hautement TABOU‼️ Et si on soignait le #CANCER mais qu’on nous le cachait sciemment ? NON, mais NON, ils n’oseraient pas, n’est-ce pas ? Et si on vous disait que certains vermifuges pour chiens pourraient être un traitement efficace contre le cancer ? Pourquoi ces résultats nous sont-ils cachés ? Quels sont les véritables intérêts de #BigPharma à nous cacher tant de vérités ? L’heure des révélations a sonné. Plus rien ne pourra les arrêter. Les témoignages se MULTIPLIENT. Écoutez ATTENTIVEMENT ces 4 vidéos que j’ai traduites, allant de #MelGibson à des médecins… ♦️ Vidéo 1 Mel Gibson Fan affirme que trois de ses amis atteints de cancer de stade 4 sont désormais en rémission, après avoir utilisé… ♦️ Vidéo 2 Dr. Kathleen Ruddy confirme que des patients en phase terminale de cancer ont guéri de manière spectaculaire après avoir pris de l’Ivermectine, avec des scans montrant la disparition des tumeurs… ♦️ Vidéo 3 Le Fenbendazole est de plus en plus reconnu comme un traitement anticancéreux potentiel. Il agit en déstabilisant les microtubules, ce qui perturbe la division des cellules cancéreuses et ralentit ou arrête la croissance des tumeurs. ♦️Vidéo 4 Joe Tippens, atteint d’un cancer du poumon en phase terminale avec moins de 1 % de chances de survie, attribue SA guérison à l’utilisation du Fenbendazole, un médicament pour animaux, après avoir reçu le conseil d’un vétérinaire. Trois mois plus tard, son cancer avait disparu, laissant les médecins PERPLEXES. 🇺🇸🚨⚠️ Highly TABOO alert‼️ What if cancer could be cured, but we were deliberately kept in the dark? NO, but NO, they wouldn’t dare, would they? What if we told you that some dog dewormers could be an effective treatment for cancer? Why are these results being hidden from us? What are the real interests of Big Pharma in concealing such truths? The time for truth has arrived. Nothing will stop them now. The testimonies are MULTIPLYING. Listen CLOSELY to these 4 videos I translated, from #MelGibson to doctors… ♦️ Video 1: Mel Gibson claims that three of his friends diagnosed with stage 4 cancer are now in remission after using… ♦️ Video 2: Dr. Kathleen Ruddy confirms that terminal cancer patients have made dramatic recoveries after taking Ivermectin, with scans showing the disappearance of tumors… ♦️ Video 3: Fenbendazole is increasingly recognized as a potential anti-cancer treatment. It works by destabilizing microtubules, disrupting cancer cell division, and slowing or stopping tumor growth. ♦️ Video 4: Joe Tippens, diagnosed with terminal lung cancer and given less than a 1% chance of survival, credits his recovery to the use of Fenbendazole, a pet medication, after receiving advice from a veterinarian. Three months later, his cancer had disappeared, leaving doctors PERPLEXED. #NCSWIC ♦️🇫🇷 Mes précédents postes sur Mel Gibson / 🇺🇸 My previous posts about Mel Gibson ➡️ & ➡️ ♦️ Source vidéos The Vigilant Fox 🦊 🇺🇸🦅🇫🇷 Sylvia Miami 🇫🇷🦅🇺🇸 🔴 Tous mes liens en un seul clic, suivez-moi / All my links in one click, follow me ✅ Donald J. Trump General Mike Flynn Elon Musk Robert F. Kennedy Jr #sylviamiami #Actu #Tendance #Infos #Monde #trump #maga #MAHA #RFKjr #RobertFKennedyJr #elonmusk #Cancer #Ivermectine #Fenbendazole #TraitementsAlternatifs #NaturalHealing #Ivermectin #Health #Remission #AlternativeTreatments

Sylvia Miami

164,600 görüntüleme • 1 yıl önce